Barcelona-based DeepUll raised €50 million in Series C funding to validate UllCORE, a rapid sepsis diagnostic tool. The test identifies 95% of sepsis pathogens within an...
This is not the first round of funding DeepUII has closed. In July 2020, the company raised its first round of €3.5 million with the support...